Member Info for ROCKZ

Not sure what’s going on with this LSE page today but I can only see 6 posts since midnight and can’t view my own post from earlier.
Very pleased though with my top ups today of 10k and 6k. Very excited about Accustem also.
I have a feeling we are going to be pretty happy with the result once this lists.
Although the company is a separate entity to Tiziana I believe a positive listing will bring investor confidence to Tiziana once investors see the BOD delivering this first in class test to market.

https://www.proactiveinvestors.co.uk/companies/amp/news/929555

GK, as of yet, the only valuation we have for Accustem is the HC Wainwright valuation of $280 million.

The clinical trial of Foralumab for COVID-19 patients in Brazil is too early and the cohort size to small to carry any muscle at government level.
What it did achieve was to provide the company with the data and confidence to plan ahead for a larger Phase 2b trial, that they have done. They have recruited the expertise to carry on the process and expand the company.
Big pharma are aware of the early results and are watching carefully.
Governments will be tripping over themselves if the next trial is positive. They will want treatments to be available ‘at the ready’ to protect themselves and their economy in case this virus keeps mutating or a similar virus lands in the future.
The bottom line is, national debt levels are huge and governments will be doing everything they can in the very near future to insure themselves and treatments are the best way of doing so.

LBC, I wouldn’t call myself a ramper, more a believer and I have posted some of my buys in the past.
I am yet to sell a share in TILS yet and managed to free up some funds this week so currently debating with myself whether to go for another TILS top up or to stay on the sidelines for a chunky Accustem top up upon listing.

Haha got to laugh, Bombay Sapphire is back making SP predictions with absolutely no understanding of the company.
Last time he posted he thought the company was working on a vaccine haha.
5 others have recommended his post!

It’s certainly going to be interesting once Accustem does list.
I wonder how many who post here are going to bail out straight away and how many see it as a mid-long term hold. Each to their own is the way I see it.
Maybe some finance has freed up for some of the big boys who may look to take a position.
How’s the SP going to move?
I’m holding for the record.

It’s obvious that KS and the team are well connected. He confirmed that he is in constant touch with big pharma in terms of what they expect for phase 2 trials.
Big pharma also steered him towards using Foralumab for MS when there were other options in the short term for the trials, Alzheimer’s etc.

Stims, her name was Keiran Shah, finance officer, she seemed on the ball, quick but to the point with her answers.
She confirmed that Accustem is currently going through the regulatory process of delivering shares to ADR shareholders. She wouldn’t commit to a timescale on this.

On a selfish note I’m hoping that any major rise from the £2 mark comes after 5th April.
That would give me the opportunity to transfer my shares from a trading account into an ISA account to take up my 21/22 ISA allocation without getting hit with too much tax.

I definitely heard them say a few weeks too.
The Dr Howard Weiner video on Bloomberg maybe, I haven’t got time to look now but will check later unless someone else can check first?

Did a dummy sell a few hours ago and couldn’t sell £500 worth..
Did a dummy sell a minute ago and offer made for £30,000 worth..

Bombay, there are also loads of stories of guys who held blockchain and NCYT who sold out before the rise. Gut wrenching.
If you keep jumping around stocks you will always hit some hot stocks occasionally. You will also hit some cold stocks, that’s the problem.
TILS is a stock to just hold for now until it bears fruit and it’s encouraging to see the kind of rises achieved by Blockchain and NCYT when the big guns pile in.

Still here, still calm, didn’t expect the drop in the last week considering no bad news but hey....
Last top up was £1.45, I’m all in for now but will top up again at these levels if funds become available.

Mr Henry, patent application is in for this method, they have covered this base.
https://www.tizianalifesciences.com/news-item?s=2020-07-31-tiziana-announces-submission-of-a-patent-application-for-nasal-administration-of-foralumab-a-fully-human-anti-cd3-monoclonal-antibody-for-treatment-of-covid-19-patients

Just adding to a very good post by Pixie, the Astra Zeneca MAB, AZD7442 is a combination of two mAbs discovered by Vanderbilt University Medical Center and licensed to AstraZeneca in June 2020.
This emphasises the previous point that big pharma don’t always get involved in early development and it can be more suitable for them to in license.

Axe (or others) out of interest, do you trade the arbitrage here?
I haven’t sold any TILS as of yet, only accumulated including today but looking at the arbitrage option for a small trading pot. Not sure it’s worth while though...
If I’m correct, even if you’re trading within an ISA you still have to pay the 15 per cent tax to the IRS.
Trading within a SIPP becomes a different matter because tax can be zero per cent which therefore makes it a must to flip flop between the two in my book... It depends on the persons age I suppose and when they intend on drawing their money from the stock market to enjoy it.

Axe, you’ve obviously had a good day, fair play.
Interesting that you favour SNG over TILS as your long term hold. I know many here are in both, I’m only in TILS. Comparing the two companies, I would suggest that public opinion has TILS as the underdog. Volume is better on SNG and BB is always busy over there.
I hope it comes good for people but for me, I prefer the TILS tech and think the US will buy into it eventually which ultimately is where the big money is.

True Blue, annoying when you’re trying to buy online but there are no shares and the price keeps going up. Ah well, not for me to worry about!

Exciting times ahead Shiraz, I’m not selling a bean, the SP will come good.
Pass on our regards to our passionate old Yankee friend BBC Cashmoney/aka Teabag.
I actually agreed with him about the market manipulation but not his scattergun approach blaming GC for insider trading and the Brits for the arbitrage trading.